NEW THIAZOLIDINEDIONE, OXAZOLIDINEDIONE AND OXADIAZOLIDINEDIONE DERIVATIVES
申请人:Astra Aktiebolag
公开号:EP0991632A1
公开(公告)日:2000-04-12
US6288096B1
申请人:——
公开号:US6288096B1
公开(公告)日:2001-09-11
[EN] NEW THIAZOLIDINEDIONE, OXAZOLIDINEDIONE AND OXADIAZOLIDINEDIONE DERIVATIVES<br/>[FR] NOUVEAUX THIAZOLIDINEDIONES, OXAZOLIDINEDIONES ET DERIVES D'OXAZOLIDINEDIONES
申请人:ASTRA AKTIEBOLAG
公开号:WO1998057941A1
公开(公告)日:1998-12-23
(EN) Novel thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives, process for their manufacture, pharmaceutical preparations containing them and the use of the compounds in conditions associated with insulin resistance.(FR) L'invention concerne de nouveaux thiazolidinediones, oxazolidinediones, dérivés d'oxazolidinediones ainsi que leur procédé de production, les préparations pharmaceutiques les contenant et l'utilisation de ces composés dans des états liés à la résistance insulinique.
Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
申请人:AstraZeneca AB
公开号:US06288096B1
公开(公告)日:2001-09-11
Novel thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives, process for their manufacture, pharmaceutical preparations containing them and the use of the compounds in conditions associated with insulin resistance.